The Gist Matthew Schrag Alzheimer's Whistle Blower, and Chuck Schumer Democratic Pain Sponge
4 snips
Mar 14, 2025 Matthew Schrag, a physician and neuroscientist who investigates research integrity and exposed major problems in Alzheimer’s studies, discusses the amyloid hypothesis and how image manipulation and institutional pressures shaped the field. He describes forensic review, the Cassava Sciences controversy, evolving detection tools and the social forces that kept a flawed paradigm alive.
AI Snips
Chapters
Books
Transcript
Episode notes
Amyloid Hypothesis Became The Field's Default
- The dominant amyloid hypothesis framed beta amyloid plaques as the primary driver of Alzheimer's and guided decades of research and drug strategies.
- Genetic links in rare familial cases elevated plaques to a central theory that shaped funding and therapeutic focus.
Consulting Job Led To Cassava Sciences Exposé
- Schrag was hired by short sellers and others to examine Cassava Sciences' data and found numerous red flags in images supporting the drug simufilam.
- The company lost roughly $5 billion in market cap and its trial later failed after integrity concerns emerged.
Image Forensics Exposed Directional Data Manipulation
- Image forensics revealed repeated copy-paste manipulations across influential papers, indicating directional alteration rather than random mistakes.
- Detecting clone segments and reused images showed manipulation intended to prove a thesis.
